Arbutus Biopharma | Investor Presentation Deck | 28 slides · page 18 of 28
The slide outlines a clinical trial design with two main arms involving AB-729, VTP-300, and optional Nivolumab.
Pitch deck · appendix_methodology · plan_implementation · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
diagram 1/1 image 2/2 paragraph 2/2 source-note 1/1 title 1/1
Components 7
timeline logo logo paragraph paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1